Cargando…

Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia

INTRODUCTION: To assess the frequency of allergic reactions to asparaginase (ASP) and possible risk factors for reactions in a cohort of pediatric patients. METHOD: The study was performed based on retrospective data from patients under acute lymphoid leukemia treatment in a general university hospi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Battistel, Ana Paula, Rocha, Bruno Simas da, Santos, Maitê Telles dos, Daudt, Liane Esteves, Michalowski, Mariana Bohns
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910154/ https://www.ncbi.nlm.nih.gov/pubmed/32014473 http://dx.doi.org/10.1016/j.htct.2019.10.007

Ejemplares similares

Asparaginase: an old drug with new questions
por: Cecconello, Daiane Keller, et al.
Publicado: (2020)

Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
por: Cecconello, Daiane Keller, et al.
Publicado: (2020)

Follow our path with asparaginase activity: one technique, but different uses in clinical practice
por: Cecconello, Daiane Keller, et al.
Publicado: (2022)

Influence of minimal residual disease by multiparametric flow cytometry at day 15 of induction in risk stratification of children with B-cell acute lymphoblastic leukemia treated at a referral hospital in southern Brazil
por: Silva, Klerize Anecely de Souza, et al.
Publicado: (2020)

Antibiotic prophylaxis in acute childhood leukemia: What is known so far?
por: Dufrayer, Mauro Cesar, et al.
Publicado: (2023)

From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies
por: Oliveira, Claudia de Melo, et al.
Publicado: (2022)

Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil
por: Dufrayer, Mauro Cesar, et al.
Publicado: (2023)

Could CD64 expression be used as a predictor of positive culture results in children with febrile neutropenia?
por: Barbosa, Gustavo Göhringer de Almeida, et al.
Publicado: (2015)

Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL
por: Sari, Nur Melani, et al.
Publicado: (2023)

Epidemiological evaluation and survival of children with acute myeloid leukemia
por: Morais, Rahuany Velleda de, et al.
Publicado: (2020)

The impact of COVID-19 in children with Sickle Cell Disease: Results of a multicentric registry
por: Oliveira, Claudia de Melo, et al.
Publicado: (2023)

Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification
por: Brum da Silva Nunes, Vitória, et al.
Publicado: (2022)

Comment on: clinical impact of systematic nutritional care in adults submitted to allogeneic hematopoietic stem cell transplantation
por: Daudt, Liane Esteves
Publicado: (2012)

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019)

SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE : INCIDENCE OF SENSITIVITY AMONG LEUKEMIAS OF VARIOUS TYPES: COMPARATIVE INHIBITORY ACTIVITIES OF GUINEA PIG SERUML-ASPARAGINASE AND ESCHERICHIA COLI L-ASPARAGINASE
por: Boyse, Edward A., et al.
Publicado: (1967)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
por: Sassen, Sebastiaan D.T., et al.
Publicado: (2017)

What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
por: Bosi, Guilherme Rasia, et al.
Publicado: (2019)

Reactions related to asparaginase infusion in a 10-year retrospective cohort
por: Santos, Amanda Cabral dos, et al.
Publicado: (2017)

HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY
por: Farias, Mariela Granero, et al.
Publicado: (2020)

L-Asparaginase induced thrombosis in acute lymphoblastic leukemia
por: Kulkarni, Ketan P.
Publicado: (2012)

Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
por: Hijiya, Nobuko, et al.
Publicado: (2016)

L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
por: Egler, Rachel A., et al.
Publicado: (2016)

Antiproliferative effects of L-asparaginase in acute myeloid leukemia
por: Chen, Tingting, et al.
Publicado: (2020)

A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines
por: Sugimoto, Koichi, et al.
Publicado: (2015)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020)

Asparaginase-Induced Hypertriglyceridemia Presenting as Pseudohyponatremia during Leukemia Treatment
por: Hinson, Ashley, et al.
Publicado: (2014)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
por: M'harzi, Soulaimane, et al.
Publicado: (2022)

Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
por: Zhang, Wunan, et al.
Publicado: (2021)

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
por: Vrooman, Lynda M., et al.
Publicado: (2015)

Efficacy and safety of PEG-asparaginase versus E. coli L-asparaginase in Chinese children with acute lymphoblastic leukemia: a meta-analysis
por: Dai, Zhan-Jing, et al.
Publicado: (2021)

Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia
por: Avramis, Vassilios I, et al.
Publicado: (2006)

Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells
por: Song, Ping, et al.
Publicado: (2015)

L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia
por: Saburi, Masuho, et al.
Publicado: (2020)

Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase
por: Hlozkova, Katerina, et al.
Publicado: (2020)

L-Asparaginase Toxicity in the Treatment of Children and Adolescents with Acute Lymphoblastic Leukemia
por: Schmidt, Madalina-Petronela, et al.
Publicado: (2021)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
por: Chenbah, Wafa, et al.
Publicado: (2023)

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
por: Ferguson, Daniel C., et al.
Publicado: (2022)

Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross‐sectional nationwide study in Spain
por: Lassaletta, Álvaro, et al.
Publicado: (2022)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
por: Khalil, Alaeddin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekmgpajqtrttotsctdvbq6bell